These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 7510563

  • 21. Use of several second generation serological assays to determine the true prevalence of hepatitis C virus infection in haemophiliacs treated with non-virus inactivated factor VIII and IX concentrates.
    Watson HG, Ludlam CA, Rebus S, Zhang LQ, Peutherer JF, Simmonds P.
    Br J Haematol; 1992 Apr; 80(4):514-8. PubMed ID: 1581236
    [Abstract] [Full Text] [Related]

  • 22. Viral hepatitis comparative epidemiology.
    Wright R.
    Br Med Bull; 1990 Apr; 46(2):548-58. PubMed ID: 2116217
    [Abstract] [Full Text] [Related]

  • 23. Hepatitis C in haemophilia: lights and shadows.
    Rumi MG, De Filippi F, Santagostino E, Colombo M.
    Haemophilia; 2004 Oct; 10 Suppl 4():211-5. PubMed ID: 15479400
    [Abstract] [Full Text] [Related]

  • 24. Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies.
    Kawatani T, Suou T, Tajima F, Ishiga K, Omura H, Endo A, Ohmura H, Ikuta Y, Idobe Y, Kawasaki H.
    Eur J Haematol; 2001 Jul; 67(1):45-50. PubMed ID: 11553266
    [Abstract] [Full Text] [Related]

  • 25. Prevalence of hepatitis C antibodies in patients with clotting disorders in Victoria. Relationship with other blood borne viruses and liver disease.
    Leslie DE, Rann S, Nicholson S, Fairley CK, Gust ID.
    Med J Aust; 1992 Jun 01; 156(11):789-92. PubMed ID: 1321326
    [Abstract] [Full Text] [Related]

  • 26. Antibody to hepatitis C (anti C 100-3) in French hemophiliacs.
    Maisonneuve P, Laurian Y, Guerois C, Verroust F, Ferrer Le Coeur F, Couroucé AM, Noel L.
    Nouv Rev Fr Hematol (1978); 1991 Jun 01; 33(3):263-6. PubMed ID: 1956764
    [Abstract] [Full Text] [Related]

  • 27. Antibodies to hepatitic C virus and chronic liver disease among Finnish patients with haemophilia.
    Ebeling F, Rasi V, Naukkarinen R, Leikola J.
    Ann Med; 1990 Dec 01; 22(6):393-6. PubMed ID: 1963789
    [Abstract] [Full Text] [Related]

  • 28. Hepatitis C antibody and chronic liver disease in haemophilia.
    Makris M, Preston FE, Triger DR, Underwood JC, Choo QL, Kuo G, Houghton M.
    Lancet; 1990 May 12; 335(8698):1117-9. PubMed ID: 1971863
    [Abstract] [Full Text] [Related]

  • 29. The natural history of chronic hepatitis C in haemophiliacs.
    Makris M, Preston FE, Rosendaal FR, Underwood JC, Rice KM, Triger DR.
    Br J Haematol; 1996 Sep 12; 94(4):746-52. PubMed ID: 8826904
    [Abstract] [Full Text] [Related]

  • 30. Hepatitis B, C, and D virus infections in patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma: a comparative study in Niger.
    Cenac A, Pedroso ML, Djibo A, Develoux M, Pichoud C, Lamothe F, Trepo C, Warter A.
    Am J Trop Med Hyg; 1995 Apr 12; 52(4):293-6. PubMed ID: 7537942
    [Abstract] [Full Text] [Related]

  • 31. Peripheral mononuclear cells of haemophiliacs with chronic liver disease are infected with replicating hepatitis C virus.
    Henin C, Makris M, Brown J, Peake IR, Preston EF.
    Br J Haematol; 1994 May 12; 87(1):215-7. PubMed ID: 7947252
    [Abstract] [Full Text] [Related]

  • 32. Interferon treatment of chronic hepatitis C in patients with hemophilia or von Willebrand's disease in Japan.
    Yoshikawa M, Fukui H, Kojima H, Yoshiji H, Sakamoto T, Imazu H, Nakanani T, Matsumura Y, Kuriyama S, Yamao J.
    J Gastroenterol; 1995 Jun 12; 30(3):367-71. PubMed ID: 7647904
    [Abstract] [Full Text] [Related]

  • 33. Recent advances in the hepatitides.
    Ramos-Soriano AG, Schwarz KB.
    Gastroenterol Clin North Am; 1994 Dec 12; 23(4):753-67. PubMed ID: 7698831
    [Abstract] [Full Text] [Related]

  • 34. Coinfection with hepatitis viruses and human immunodeficiency virus in multiply transfused patients.
    Brenner B, Back D, Ben-Porath E, Hazani A, Martinowitz U, Tatarsky I.
    Isr J Med Sci; 1994 Dec 12; 30(12):886-90. PubMed ID: 8002269
    [Abstract] [Full Text] [Related]

  • 35. Transfusion-dependent thalassemia: viral complications (epidemiology and follow-up).
    de Montalembert M, Girot R, Mattlinger B, Lefrère JJ.
    Semin Hematol; 1995 Oct 12; 32(4):280-7. PubMed ID: 8560285
    [No Abstract] [Full Text] [Related]

  • 36. Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial.
    Bresters D, Cuypers HT, Reesink HW, Mauser-Bunschoten EP, van den Berg HM, Schaasberg WP, Wilber JC, Urdea MS, Neuwald P, Lelie PN.
    J Med Virol; 1994 Jul 12; 43(3):262-8. PubMed ID: 7931188
    [Abstract] [Full Text] [Related]

  • 37. Review of the transmission of hepatitis by clotting factor concentrates.
    Tabor E.
    Scand J Haematol Suppl; 1984 Jul 12; 40():303-8. PubMed ID: 6433456
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Chronic viral hepatitis: diagnosis and management.
    Maddrey WC.
    Hosp Pract (Off Ed); 1994 Feb 15; 29(2):117-20, 123-6, 129-32. PubMed ID: 8300760
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.